Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Horizon Discovery Group announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines.
read more
Wednesday, January 02, 2019
HOOKIPA Pharma announced that it has achieved its first research milestone in its collaboration and license agreement with Gilead Sciences.
read more
Hongene Biotech Corporation entered a non-exclusive licensing agreement with the UMass Chan Medical School to produce and supply extended nucleic acid (exNA) monomers and exNA-modified oligonucleotides for research use.
read more
Hongene has appointed Dr. Pieter Cullis, a renowned innovator in lipid nanoparticle (LNP) drug delivery, to its scientific advisory board. This strategic addition reinforces Hongene’s commitment to advancing RNA therapeutics.
read more
Monday, September 09, 2024
Hongene Biotech Corporation, a nucleic acid manufacturing company, and ReciBioPharm, an advanced therapeutics CDMO services provider, have announced a strategic collaboration that will enhance gene editing drug manufacturing capabilities.
read more
Hongene Biotech Corporation announced its role in advancing DNV001, a novel GalNAc-conjugated siRNA targeting dyslipidemia. The therapy, developed by Hangzhou Dingle Xinwei Biotechnology, recently received investigational new drug (IND) clearance ...
read more
Wednesday, March 17, 2021
HomTex has received EUA for its Level 1 Surgical masks, greenlighting their entry into the US government and medical PPE markets.
read more
In Sisseln, Switzerland, high-quality tablets, granules, effervescent tablets and hard capsules are produced by Aenova on a footprint of more than 6,000 m2 and a production area of more than 1,900 m2 by 160 employees - and with a completely CO2-free ...
read more
Wednesday, March 11, 2020
HitGen and Kaken Pharmaceutical have entered into a license agreement to develop a novel class of drugs.
read more
Monday, November 27, 2017
HitGen announced the company has entered into a drug discovery research collaboration with Boehringer Ingelheim.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
HitGen has extended and expanded its agreement with Merck into a multi-year research collaboration and license agreement to build and screen novel DNA-encoded libraries.
read more
HitGen has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of interest to Gilead.
read more
HitGen announced it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ.
read more
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) announced they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare company
read more